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ApoptosisThe cervical epithelial cell line, HeLa, is one of the oldest and most commonly used cell lines in cell biology
laboratories. Although a truncated P2X7 receptor has recently been identiﬁed in HeLa cells, the expression of
other purinergic receptors or the function of the P2X7 protein has not been characterized. We here show that
HeLa cells express transcripts for most P2X and P2Y purinergic receptors. Treatment of cells with ATP or other
P2X7 agonists does not stimulate cell death, but can induce atypical calcium ﬂuxes and ion currents. Cervical
epithelial cells represent an important target for sexually-transmitted pathogens and are commonly exposed
to pro-inﬂammatory cytokines such as IFNγ. Stimulation of HeLa cells with IFNγ upregulates expression of
P2X7 mRNA and full-length protein, modiﬁes ATP-dependent calcium ﬂuxes, and renders the cells sensitive
to ATP-induced apoptosis, which can be blocked by a P2X7 antagonist. IFNγ treatment also increased
dramatically the sensitivity of the intestinal epithelial cell line, HCT8, to ATP-induced apoptosis. Signiﬁcantly,
IFNγ also stimulated P2X7 expression on human intestinal tissues. Responses to other purinergic receptor
ligands suggest that HeLa cells may also express functional P2Y1, P2Y2 and P2Y6 receptors, which could be
relevant for modulating ion homeostasis in the cells.© 2009 Elsevier B.V. All rights reserved.1. Introduction
Extracellular nucleotides are signalling molecules that exert effects
on a variety of tissues, mainly via interactionwith speciﬁc membrane-
bound receptors [1]. The target-cell responses are mediated by P2
receptors named either P2X or P2Y. P2X receptors are ligand-gated ion
channels, and P2Y receptors are coupled to trimeric G-proteins [2].
Seven members of the P2X family in mammals have been cloned
(P2X1–7) [3], and eight P2Y receptors (P2Y1, P2Y2, P2Y4, P2Y6, P2Y11,
P2Y12, P2Y13 and P2Y14) [4,5].
Activation of the P2X7 receptors leads to opening of a plasma
membrane pore, inducing the permeabilization of the cells to
molecules up to 800 Da; although not all cells display pore formation
in response to P2X7 ligation [3]. The P2X7 receptor is responsible foredium; IFNγ, interferon-γ; IL-
pase C; TNFα, tumor necrosis
osphate
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ll rights reserved.the release of pro-inﬂammatory cytokines such as IL-1β and
subsequently IL-6 in murine and human macrophages and mast
cells [6,7], induction of apoptosis in different cell types [6,8], and
elimination of intracellular parasites in macrophages [9–12].
Although most studies on purinergic receptors have been
performed with cells from the central nervous system or macro-
phages, various P2X and P2Y receptors have also been described
recently in epithelial cells from different sources [13,14]. Thus, human
intestinal epithelial cells express mRNA for P2X1, P2X3, P2X4, P2X5,
P2X6, P2X7, P2Y1, P2Y2, P2Y4, P2Y6, P2Y11 and P2Y12, and the functional
presence of P2X7, P2Y1, P2Y2 and P2Y4 has been conﬁrmed based on
the effect of extracellular nucleotides on apoptosis, cell proliferation,
and calcium ﬂuxes [15]. The P2X7 receptor is also expressed in the
murine gut epithelium, where its expression is associated with cell
death [16]. While parotid acinar epithelial cells do not express
functional P2X7, duct cells express functional receptor [17], showing
a restricted distribution of some receptors even within the same
organ. The P2Y1 and P2Y2 receptors are also involved with ATP-
induced calcium signaling in airway epithelial cells [18,19], and P2Y2
has been linked with inhibition of growth of human eosophageal
squamous and colorectal carcinoma cells [20,21]. Finally, the P2Y4 and
P2Y6 receptors control chloride transport in jejunum and colon
epithelial cells, respectively [22,23].
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been fully characterized on the cervical epithelial cell line, HeLa, which
represents the “work horse” of many cell biology and microbiology
laboratories [24]. The uterine cervical epithelium is maintained by a
balance between proliferation of a basal layer of cells, and death of
cells in the upper layer. They regulate lubrication of the genital tract,
represent a barrier against invasion by pathogens, and provide the
necessary conditions for reproduction. Recently it has been shown
that extracellular ATP mediates apoptosis via P2X7 in hECE and CaSki,
two human cervical epithelial cell lines; and that estrogen, epinephr-
ine, and epidermal growth factor, combined with epinephrine, inhibit
P2X7-receptor-mediated pore formation and apoptosis in these cells
[25–27]. HeLa cells, a human cervical carcinoma cell line that is used as
a model host cell for infection by pathogens that infect the cervical
epithelium but also other tissues [28–32], express P2Y2 and P2Y6
receptors [33,34] and a truncated form of P2X7 [35]. However, given
the presence of the truncated P2X7 [35] and the effect of a PLC
inhibitor on calcium signaling, it was assumed that HeLa cells do not
express functional P2X purinergic receptors [33]. In addition, the
functional expression of other P2 receptors on this cell line has never
been investigated fully. We therefore examined whether other P2X
and P2Y receptors may be expressed in epithelial HeLa cells, have
begun to identify their cellular behavior, and have re-addressed the
question of whether P2X7 on HeLa cells may be functional. As cervical
epithelial cells are also a common site of infection with sexually-
transmitted pathogens, most of which initiate a strong inﬂammatory
response [36–38], we also investigated whether the pro-inﬂammatory
cytokines, IFNγ and TNFα, may modulate the expression or activity of
P2X7 receptors on HeLa cells.
2. Materials and methods
2.1. Cells and materials
The human cervical adenocarcinoma cell line, HeLa229, was from
the American Type Culture Collection (ATCC; Manassas, VA). The cells
were cultured in a humidiﬁed incubator at 37 °C with 5% CO2 in
Dulbecco's modiﬁed minimal essential medium (DMEM) with
Glutamax-1 (Life Technologies, Inc.; Rockville, MD) supplemented
with 10% heat-inactivated fetal calf serum (FCS) and 25 μg/ml
gentamicin. Recombinant human IFN-γ and TNFα were from BD
Biosciences Pharmingen (San Jose, CA). All nucleotides were pur-
chased from Sigma-Aldrich (St. Louis, MO). Fura-2 was obtained from
Molecular Probes (Eugene, OR). Unless speciﬁed otherwise, all other
reagents were purchased from Sigma. The nucleotides were prepared
as 100 mM stock solution in PBS and stored at −20 °C until use.
2.2. RT-PCR detection of nucleotide receptors
RNA from HeLa cells was isolated using an RNeasy kit (Qiagen),
following the manufacturer's instructions. Total RNA was converted
into cDNA by standard reverse transcription with Superscript II Rnase
H− Reverse Transcriptase in the manufacturer's buffer (Invitrogen,
Life Technologies; Carlsbad, CA). cDNAs were ampliﬁed using the
iCycler (BIO-RAD laboratories, Richmond, CA) in a 50 μl reaction
mixture containing one-ﬁfteenth of the cDNA generated from reverse
transcription reaction, 1× PCR buffer, 2.5 mM MgCl2, 0.25 mM (each)
dNTPs, 0.5 μM forward and reverse primers, and 1 U HotGoldstar DNA
polymerase (Eurogentec, Seraing, Belgium). Ampliﬁcation was done
with the following sequences: GAPDH: 5′-AACGGATTTGGTCG-
TATTGGGC-3′, 5′-CTTGACGGTGCCATGGAATTTG-3′; P2X1: 5′-
GCTGGTGCGTAATAAGAAGGTG-3′, 5′-ATGAGGCCGCTCGAGGTCTG-3′;
P2X2: 5 ′-AGGTTTGCCAAATACTACAAGATC-3 ′ , 5 ′-GCTGA-
ACTTCCCGGCCTGTC-3′; P2X3: 5′-CTTCACCTATGAGACCACCAAG-3′,
5′-CGGTATTTCTCCTCACTCTCTG-3′; P2X4: 5′-GATACCAGCTCAGGAG-
GAAAAC-3′, 5′-GCATCATAAATGCACGACTTGAG-3′; P2X5: 5′-GGCA-TTCCTGATGGCGCGTG-3′, 5′-GGCACCAGGCAAAGATCTCAC-3′; P2X6:
5′-AGCACTGCCGCTATGAACCAC-3′, 5′-AGTGAGGCCAGCAGCCAGAG-
3′; P2X7: 5′-TGATAAAAGTCTTCGGGATCCGT-3′ , 5′-TGGACA-
AATCTGTGAAGTCCATC-3′; P2Y1: 5′-CTTGGTGCTGATTCTGGGCTG-3′,
5′-GCTCGGGAGAGTCTCCTTCTG-3′; P2Y2: 5′-CCGCTCGCTGGACCT-
CAGCTG-3 ′ , 5 ′-CTCACTGCTGCCCAACACATC-3 ′; P2Y4: 5 ′-
CGCTGCCCACCCTCATCTAC-3′, 5′-CCGAGTGGTGTCATGGCACAG-3′;
P2Y5: 5′-TGTTCAGTCTACCCACTCTCAG-3′, 5′-CTTACTGCTGCCACTACT-
GAGC-3′; P2Y6: 5′-AACCTTGCTCTGGCTGACCTG-3′, 5′-GCAGG-
CACTGGGTTGTCACG-3′; P2Y8: 5′-CTCCTGGCGCACATCGTGAG-3′, 5′-
GGAGCGCACGGACGTGGTC-3′; P2Y10: 5′-GGTGTTCATGTGTGCTG-
CAGTC-3′, 5′-ATGGCGGGATAGTTGGTCACG-3′; P2Y11: 5′-GAGGCCTG-
CATCAAGTGTCTG-3′, 5′-ACGTTGAGCACCCGCATGATG-3′; P2Y12: 5′-
ACCGGTCATACGTAAGAACGAG-3′, 5′-GCAGAATTGGGGCACTTCAGC-
3′; P2Y13: 5′-GGAAGCAACACCATCGTCTGTG-3′, 5′-GACTGTGAGTA-
TATGGAACTCTG-3′; and P2Y14: 5′-CCGCAACATATTCAGCATCGTG-3′,
5′-ACATTTGCAGCAGATAGTAGCAG-3′. The PCR cycling protocol for all
primers was 94 °C at 45 s, 60 °C at 45 s, 72 °C at 45 s. The protocol was
conducted for 40 cycles and included an initial 10-min enzyme
activation step at 95 °C and a ﬁnal 10-min extension step at 72 °C. PCR
products were separated by electrophoresis on a 2% agarose gel and
visualized by ethidium bromide staining. Peripheral blood lympho-
cytes were used as a positive control for expression of all the P2X
receptors. The human laryngeal epithelial carcinoma cell line Hep2
was used to verify expression of all P2Y receptors.
2.3. Real-time PCR for P2X7 mRNA from HeLa cells
RNA from HeLa cells was isolated using an RNeasy kit (Qiagen)
following the manufacturer's instructions. Total RNA was converted
into cDNA by standard reverse transcription with Superscript II Rnase
H− Reverse Transcriptase in the manufacturer's buffer (Invitrogen).
Quantitative PCR was performed with one-ﬁfteenth of the cDNA
preparation in an Mx3000P (Stratagene; La Jolla, CA) in 25 μl ﬁnal
volume with Brilliant QPCR Master Mix (Stratagene). cDNA was
ampliﬁed using 300 nM of P2X7 forward primer, 100 nM of P2X7
reverse primer or 400 nM of GAPDH forward and reverse primers. We
also used 300 nM of the ﬂuorogenic oligonucleotides speciﬁc for the
gene segments inwhich a reporter ﬂuorescent dye on 5′ (FAM®) and a
quencher dye on 3′ (TAMRA®) were attached. Real-time PCR was
carried out at 95 °C for 10 min, followed by 40 cycles at 95 °C for 30 s,
60 °C for 1 min. The speciﬁc activities of cDNA from P2X7 were
compared with GAPDH and normalized to untreated control HeLa
cells by the comparative CT method as described by the manufacturer.
For human GAPDH, the primers used were as follows: sense primer, 5-
GAGAAGGCTGGGGCTCAT-3′; antisense primer, 5′-TGCTGATGATCTT-
GAGGCTG-3′; probe, 5′-CTCTGCTGATGCCCCCATGTTCGT-3′. For P2X7,
the primers used were as follows: sense primer, 5′-CTTTCTCAAAA-
CAGAAGGCCAAGA-3′; antisense primer, 5′-CAACCTCGGTCAGAGGAA-
CAGA-3′; probe, 5′-TGTGTCCCGAGTATCCCACCCGC-3′.
2.4. Measurement of cell death by cytoﬂuorimetry
HeLa cells were incubated in the presence or absence of IFNγ (0.5,
1, or 2 ng/ml) for 3 days. HeLa cells were then treated with the
indicated concentration of ATP (3 or 5 mM) in serum-free DMEM
medium for 2 h, after which the medium was replaced with DMEM
medium containing 10% heat-inactivated FCS, 25 μg/ml gentamicin, in
the absence of nucleotides. After an additional 24 h in the incubator at
37 °C, both adherent cells and cells in suspension were collected,
washed twice in PBS, and analyzed by cytoﬂuorimetry. Phosphati-
dylserine exposure on dying cells was measured by labeling with
Annexin V-FITC (R&D Systems; Minneapolis, MN), and loss of plasma
membrane integrity was measured by PI staining, as described [39].
Data from 10,000 HeLa cells were collected on a CyAn LX ﬂow
cytometer (Dako Cytomation) with a laser tuned to 488 nm.
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experiments the degree of apoptosis was determined by counting the
number of hypo-diploid nuclei after ATP treatment. In brief, HeLa and
HCT8 cells were treated as described above. The cells were incubated
with 300 μM oATP for 2 h before ATP treatment. After the ﬁnal 24 h in
the incubator at 37 °C, both adherent cells and cells in suspension
were collected, washed twice in PBS, spun for 10 min (200 ×g), and
resuspended in an apoptotic buffer containing 50 μg/ml ethidium
bromide, 0.01 g sodium citrate, and 0.1% Triton X-100. The samples
were transferred into 12×75 mm FALCON 2052 FACS tubes (Becton
Dickinson, San Jose, CA) and kept on ice until use. Data from 10,000
cells were collected on a FACScan ﬂow cytometer (Becton Dickinson)
equipped with a 488 nm argon laser. The cells acquired for analysis
were gated to eliminate cell aggregates using WinMDI software. The
cells with sub-diploid amounts of DNA were considered apoptotic.
2.5. Western blot analysis
HeLa cells were incubated in the presence or absence of IFNγ (0.2,
0.5, 2 or 5 ng/ml), or in a combination of IFNγ (0.5 or 2 ng/ml) plus
TNFα (10 or 100 ng/ml) for 2 days. After an additional 24 h in the
incubator at 37 °C in the absence of any cytokines, the cells were
collected, transferred to microfuge tubes, and washed once in cold
PBS, and the pellets were stored at −80 °C until use. Samples were
lysed in buffer containing 50 mM Tris–HCl, 150 mMNaCl, 2 mM EDTA,
1% Triton X-100 and protease inhibitor cocktail (5 μl/ml, Sigma), and
left for 30min on ice. The protein concentrationwas determined using
the micro BCA protein assay (Pierce), and 35 μg of protein were
separated on a 10% SDS-PAGE and transferred onto nitrocellulose
membranes (Amersham Biosciences; Piscataway, NJ). After blocking
in Tris-buffered saline containing 0.05% Tween 20 (TBST) and 5% BSA
for 1 h, the membranes were washed extensively in TBST and
immunostained with a rabbit polyclonal anti-P2X7 receptor antibody
(Calbiochem) diluted at 1:5000 in blocking buffer. Following three
washes with TBST, membranes were incubated with an anti-rabbit
polyclonal antibody conjugated to HRP diluted at 1:10,000 (Amer-
sham Biosciences) in TBST supplemented with 5% nonfat dry milk.
After subsequent washes, speciﬁc bands were visualized by enhanced
chemiluminescence (Amersham Biosciences).
2.6. Statistics
The effect of ATP on the viability of HeLa cells was statistically
evaluated using the Student t test. Effects of IFNγ on P2X7 expression
in the normal colonic epithelium were analyzed as the difference of
expression using the Wilcoxon signed rank test.
2.7. Organ culture and immunohistochemistry
Colonicmucosal explantswere cultured for 24h at 37 °Cwith95%O2
and 5% CO2 by standard procedures. Brieﬂy, biopsy specimens were
placed on iron grids in an organ culture dish in the presence ofmedium
alone, consisting of RPMI 1640 medium (Life Technologies), 10% fetal
calf serum, and penicillin and streptomycin (100 U/ml), or with the
addition of IFNγ (2 ng/ml). After 24 h, mucosal explants were
immediately embedded inTissue-TekO.C.T. compound (Miles Scientiﬁc
Laboratories Ltd, Naperville, IL) and snap-frozen in isopentane in a
liquid nitrogen bath. Samples were then stored at −80 °C until
processing, and cut into 5 μm sections in a cryostat maintained at
−20 °C. Tissue sections were air-dried and ﬁxed for 10 min in acetone.
P2X7 expression was evaluated using the indirect immunoperoxidase
technique. Immunohistochemical staining was performed using the
rabbit anti-P2X7 antibody (1:300 dilution; Alomone, Jerusalem, Israel).
Brieﬂy, frozen sections were incubated at room temperature with
normalhorse serumfor30minand thenwith theanti-P2X7antibody for
1h.Negative control experimentswereperformedbypre-absorbing theP2X7 receptor antibodies with homologous peptide antigens and/or by
omission of the primary P2X7 antibodies. After rinsing in PBS for 10min,
tissue sections were incubated for 30 min with a goat anti-rabbit
peroxidase conjugate IgG (Zymed Laboratories Inc.). Additional rinsing
was followed by development with a solution containing hydrogen
peroxide and diaminobenzidine, dehydrated, lightly counterstained in
Harris's hematoxylin, dehydrated again, and mounted in histological
mounting medium. Sections were examined by two independent
observers using light microscopy at ×400 magniﬁcation.
2.8. Intracellular calcium measurements
HeLa cells treated with 0, 1, or 2 ng/ml IFNγ were grown on glass
coverslips for 48 h to subconﬂuence. The cells were then loaded with
2.5 μM Fura-2-AM (Molecular Probes) for 40 min at room temperature
in culturemedium. The coverslipswerewashed inPBS andmounted ina
three-compartment superfusion chamber attached to the stage of an
inverted microscope (NIKON DIAPHOT 300 TMD) whose base was
formed by a coverslip containing the cells. The central chamber
containing the cells had a volume of 200 μl, and was perfused with
Ca2+-containing saline (PBS supplemented with 1 mM CaCl2) or Ca2+-
free saline (PBS supplemented with 1 mM EGTA) at room temperature
at a rate of 1 ml min−1. The intracellular calcium concentration of
groups of 15–30 cells was monitored continuously with the use of a
ﬂuorescence photometer (Photon Technology; Princeton, NJ). Fura-2
was excited alternately at 340 and 380 nm, and the emission at 510 nm
was measured. The ratio measurement, which is proportional to the
intracellular calcium concentration, was determined every 100 ms. The
nucleotides were injected in bolus, allowing the drugs to persist in the
presence of the cells for 1 min, or the ATP was perfused continuously
while the temperature was kept constant at 37 °C.
2.9. Electrophysiology
Cells were grown in 35 mm plastic culture dishes (Falcon) and
incubated in the presence or absence of 1 or 2 ng/ml IFNγ for 24–48 h.
The cells were then transferred to an inverted microscope (Zeiss
Axiovert 100; Carl Zeiss; Jena, Germany). The culture medium was
exchanged for an extracellular solution containing, in mM: 135 NaCl, 5
KCl, 1 MgCl2, and 10 Na-HEPES, pH 7.4. Unless speciﬁed in the text, the
experiments were performed at 23–25 °C. ATP and UTP were applied
locally to the cell of interest using a microperfusion device. Recordings
were carried out using the conventional whole cell patch-clamp
technique [40]. Ionic currents were recorded in whole cell conﬁgura-
tion, using an EPC-7 ampliﬁer (List Electronic, Darmstadt, Germany)
according to standard patch-clamping techniques [40]. Gigaohm seals
were formed after offset potential compensation, using heat-polished
micropipettes of 5–10MΩ ﬁlled with an intrapipette solution (in mM:
135 KCl, 5 NaCl, 2 MgCl2, 0.1 K-EGTA, and 10 K-HEPES, pH 7.4). ATP and
UTP were applied to the cell surface by pneumatic injection, using a
second micropipette ﬁlled with a different concentration of nucleo-
tides dissolved in extracellular solution and connected to a PPM-2
pneumatic pump (NeuroPhore BH-2 system, List). Datawere collected
using pClamp and Fetchex software, version 6.0, and a Digidata 1200
interface (Axon Instruments) and plotted using Origin software
version 4.0 (Microcal Inc.).
3. Results
3.1. Expression of P2X and P2Y mRNA on HeLa cells
In order to determine which P2X and P2Y isoforms are expressed
by cervical epithelial cells, mRNAwas isolated fromHeLa cells andwas
analyzed by RT-PCR. Ampliﬁed PCR products of the expected sizes
were obtained for P2X3 (324 bp), P2X4 (393 bp), P2X5 (142 bp), P2X6
(176 bp) and P2X7 (396 bp) (Fig. 1A). The expression was faint for
Fig. 1. P2X and P2Y mRNA is expressed in human cervical epithelial cells. (A) P2X RT-
PCR products in HeLa cells. (B) P2Y RT-PCR products in HeLa cells. Peripheral blood
lymphocytes were used as positive controls for expression of the P2X receptors. All the
PCR ampliﬁcations were performed at least 3 times.
Fig. 2. The pro-inﬂammatory cytokine IFNγ positively modulates protein and mRNA
expression of the P2X7 receptor. (A) Western blot analysis of total protein extracts from
untreated HeLa cells and HeLa cells treated with IFNγ (0.2, 0.5, 2 and 5 ng/ml) for
2 days. Lane 1: untreated HeLa cells. Lanes 2–5: cells treated with IFNγ at 0.2, 0.5, 2 and
5 ng/ml, respectively. Lane 6: the J774 macrophage cell line used as a positive control.
Upper lower arrows indicate the 70 kDa and 40 kDa bands. The results shown are
representative of two experiments performed on different days. (B) Cells were treated
with control buffer or increasing concentrations of IFNγ for 3 days. Total mRNA was
measured by real-time PCR, as described in the Materials and methods. The experiment
was performed on two separate days, with similar results.
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the housekeeping gene, GAPDH, was performed to control for the
quantity of cDNA loaded on the gel. Peripheral blood lymphocytes,
used as a positive control for expression of all the P2X receptors,
showed expression of P2X1 and P2X2 (data not shown), conﬁrming
the quality of the P2X1 and P2X2 PCR probes used for the epithelial
cells. Ampliﬁcation of P2X4 and P2X6mRNA resulted in two fragments,
one of the expected size and a second band. We had previously
observed additional fragments for P2X2 and P2X3 in macrophages,
which were ascribed to non-speciﬁc products of PCR ampliﬁcation
and alternative splicing [46]. Similarly, ampliﬁed PCR products of the
expected sizes were obtained in HeLa cells for P2Y1 (327 bp), P2Y2
(259 bp), P2Y4 (311 bp), P2Y6 (283 bp), P2Y11 (260 bp), P2Y12
(307 bp), P2Y13 (293 bp) and P2Y14 (168 bp), and also the orphans
genes P2Y5 (351 bp), P2Y8 (237 bp) and P2Y10 (227 bp) (Fig. 1B).
3.2. IFNγ modulates P2X7 receptor expression in HeLa cells
The synthesis of P2X7 receptor proteinwas then assessed with and
without pre-treatment with IFNγ, and IFNγ plus TNFα, using the
Western blot assay. As shown in Fig. 2 the 70 kD band characteristic of
the full-length P2X7 receptor [41] was present on control untreated
HeLa cells (Fig. 2A lane 1), besides an additional 40 kDa band, likely
corresponding to truncated P2X7 protein. We observed a dose-
dependent increase in levels of the full-length P2X7 receptor band
following IFNγ treatment, with the concomitant disappearance of the
40 kDa band (Fig. 2A lanes 2–5). It has been shown that the pro-
inﬂammatory cytokine TNFα has a synergistic effect on P2X7 receptor
modulation in macrophages [42,43]. The HeLa cells were thus co-
treated with different concentrations of IFNγ plus TNFα, as described
in the Materials and methods. However, the presence of TNFα did not
have an additional effect over IFNγ alone (data not shown).
3.3. Effect of IFNγ treatment on transcription of the P2X7 gene
Since IFNγ treatment had a positive effect on P2X7 receptor protein
expression, we evaluated whether IFNγ could affect P2X7 at thetranscriptional level. We thus incubated the cells with 0, 0.5, 1 or 2 ng/
ml of IFNγ for 72 h andmeasured P2X7 transcription by real-time PCR.
There was a large dose-dependent increase in the amount of P2X7
mRNA after IFNγ treatment (Fig. 2B). A noticeable effect was observed
with 0.5 ng/ml IFNγ, but became much larger after treatment with
2 ng/ml IFNγ.
3.4. HeLa cells become sensitive to ATP-induced lysis after IFNγ
treatment
HeLa cells are known to bemore resistant to ATP-induced lysis than
primary cervical cells [26]. But after treatmentwith IFNγ, theHeLa cells
became sensitive to ATP as a function of the IFNγ dose (Fig. 3A). The
mode of cell deathwas next analyzed by double-stainingwith Annexin
V and PI. We observed that untreated cells are completely resistant to
apoptosis induced by ATP, but the IFNγ-treated cells became sensitive
to ATP-mediated cell death, with characteristics of both apoptosis and
necrosis (Fig. 3B). We next investigated the effect of the irreversible
P2X7 antagonist, oATP, on apoptosis in the presence of ATP. We pre-
treated HeLa cells that were incubated with IFNγ with oATP before
incubation with ATP. Pre-treatment with oATP inhibited ATP-induced
apoptosis, further conﬁrming the IFNγ-mediated modulation of P2X7
receptor expression (Fig. 3C).
A similar effect was observed with another human epithelial cell
line, the intestinal epithelial HCT8 cells, after treatment with IFNγ. We
observed that HCT8 cells were 50% more sensitive to ATP-mediated
apoptosis than HeLa cells in the absence of IFNγ treatment, but
became very sensitive to ATP-induced apoptosis after pre-treatment
with increasing concentrations of IFNγ (Fig 3D).
To determine whether IFNγ could also modulate P2X7 receptor
expression in primary human epithelial cells, we incubated explants
of human intestinal epithelial tissue with IFNγ for 24 h and then
Fig. 3. IFNγ increases the sensitivity to ATP-mediated cell death. HeLa cells were incubated in the presence or absence of IFNγ (0.5, 1, or 2 ng/ml) for 3 days. The cells were then
treated with increasing concentrations of ATP for 2 h, and maintained in cell culture for an additional 24 h. (A) The loss of viability induced by ATP after IFNγ incubation, measured by
cytoﬂuorimetry (viable cells=cells negative for both Annexin V and PI). B shows the increase in the number of apoptotic cells after incubation with IFNγ (2 ng/ml).
Phosphatidylserine exposure on dying cells was measured by labeling with Annexin V-FITC, and loss of plasma membrane integrity was measured by PI staining. C and D show the
formation of hypo-diploid nuclei after ATP treatment in HeLa cells (C) and HCT8 cells (D). Note that the pre-treatment with 300 μM oATP inhibited ATP-induced apoptosis. The data
shown in A and B are from a representative experiment performed in triplicate repeated on two separate occasions. The data shown in C and D are mean±SEM of three and four
independent experiments performed in triplicate (⁎P b0.05 for 3 mMATP compared with 0 mM ATP, cells treated with 1 ng/ml IFNγ; ⁎⁎P b0.001 for 3 and 5mM ATP compared with
0 mM ATP, cells treated with 2 ng/ml IFNγ).
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the P2X7 receptor. We observed an increase in P2X7-speciﬁc
immunostaining on epithelial cells from explants incubated with
IFNγ (Fig. 4A–B) compared with untreated ones (Fig. 4C–D),
demonstrating that the effects of IFNγ on P2X7 expression are not
limited to epithelial cell lines. Quantiﬁcation of the effect of IFNγ on
P2X7 expression is shown in Fig. 4E.3.5. ATP and UTP elicit calcium ﬂuxes in HeLa cells
To identify the P2-receptor subtypes that may be functional in
HeLa cells, we measured changes in [Ca2+]i induced by nucleotides.
In Ca2+-containing PBS solution, successive application of ATP and
UTP (100 μM) induced a rapid transient increase of [Ca2+]i,
regardless of which nucleotide was added ﬁrst (Fig. 5A, B).
Fig. 4. Effect of IFNγ on P2X7 expression in the normal colonic epithelium. Human colonic samples from endoscopic biopsies were treated in organ cultures with or without the
addition of 2 ng/ml IFNγ for 24 h. Frozen sections were stained by immunoperoxidase using an antibody against the P2X7 receptor. A–D shows immunostaining for P2X7 receptors on
human epithelial tissues from untreated (C and D) and IFNγ-treated (A and B) samples. Sections were examined using light microscopy at ×100 (A and C) and ×400magniﬁcation (B
and D). E, The density of P2X7-positive cells is given as the percentage of immunoreactive cells among epithelial cells in the crypts and in the surface epithelium. Numbers are
representative of ﬁve different experiments. Horizontal bars represent medians, boxes represent the 25th and 75th percentiles, and vertical bars represent ranges. Differences were
analyzed using the Wilcoxon signed rank test.
1181L. Welter-Stahl et al. / Biochimica et Biophysica Acta 1788 (2009) 1176–1187Removing Ca2+ from the extracellular bath barely reduced the ATP
responses, suggesting that the main cytosolic [Ca2+]i increase was
due to release from intracellular stores (Fig. 5C). In addition, the
ATP response was only partially blocked by pre-treatment with the
P2X7 antagonist, oATP (Fig 5D), and the UTP response was
completely blocked by suramin treatment (data not shown). To
investigate possible cross-desensitization between ATP and UTP in
nucleotide-induced [Ca2+]i changes, HeLa cells were perfused with
100 μM ATP or UTP, until the [Ca2+]i response returned to basal
levels, and the cells were then exposed to 100 μM of a second
agonist (ATP or UTP) in the continued presence of the ﬁrst agonist.
As shown in Fig. 5E, UTP pre-treatment markedly, but not
completely, reduced the [Ca2+]i response to ATP, whereas ATPpre-treatment completely abolished the UTP-induced [Ca2+]i
changes (Fig. 5F). UTP and ATP promoted dose-dependent [Ca2+]i
ﬂuxes transiently, with responses starting at 100 nM for both
nucleotides, and an EC50 of 17±4 and 27±5 μM for UTP and ATP,
respectively (Fig 5G). The nucleotides UDP, ADP and αβ-meATP
also elicited changes in [Ca2+]i, beginning at 5 μM for ADP and
UDP and 25–100 μM for αβ-meATP (Fig. 5H).
3.6. IFN-γ treatment modiﬁes the pattern of ATP and UTP-induced [Ca2+]i
responses
HeLa cells were perfused with buffer saline containing 1 mM
ATP at 37 °C. Under these conditions, we observed a transient rise
Fig. 5. Effect of different nucleotides on intracellular Ca2+ ﬂuxes. HeLa cells were loaded with Fura-2, and nucleotides were added in a bolus of 1-min duration in a continuous
perfusion chamber. (A) Effects of 100 μM ATP on [Ca2+]i followed by stimulation with 100 μM UTP. (B) Same as in A, but UTP was applied ﬁrst. (C) 100 μM ATP was added in Ca2+-
containing saline (ﬁrst bar) and in calcium-free saline (second bar). (D) Effect of 100 μM ATP on [Ca2+]i in cells pre-treated with oATP. (E and F) The effect of ATP/UTP on cross-
desensitization of Ca2+ responses. (E) Addition of 100 μMATP during prolonged stimulationwith 100 μMUTP, showing a small remaining response to ATP. (F) Addition of 100 μMUTP
during prolonged stimulation with 100 μM ATP, showing that pre-stimulation with ATP blocks UTP-induced calcium responses. (G) Dose response curves for ATP- and UTP-induced
[Ca2+]i responses. Cells were exposed to the indicated concentration of ATP (open circles) or UTP (ﬁlled triangles). (H) Changes in [Ca2+]i in response to 1, 5, 10, 25, 50, 75 and 100 μM
of the indicated nucleotides. The [Ca2+]i is given as the ﬂuorescence ratio (F340/F380 nm), where ﬂuorescence is proportional to the intracellular calcium concentration. In A–F,
representative data of a single experiment with 20 cells per incubation are shown. The experiments were repeated at least three times with similar results. Values in G and H
represent mean±SEM of ﬁve (G) and six (H) independent experiments.
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n= 4) (Fig. 6A, C). The response was longer but comparable to
the response observed with a small bolus application at room
temperature. However, cells pre-incubated with 1–2 ng/ml IFNγ
for 24 h responded to ATP perfusion with a rapid biphasicincrease of [Ca2+]i, followed by a sustained plateau that slowly
(4–5 min) (267±28 s, n= 5) returned to [Ca2+]i basal levels
(Fig. 6B, C), compatible with the opening of a non-selective pore
on the plasma membrane, as demonstrated for P2X7 in other cell
types [6,8,41,44]. The pre-treatment with the P2X7 receptor
Fig. 6. Effect of IFNγ on ATP- and UTP-induced Ca2+ responses. (A) Untreated cells under perfusionwith 1 mMATP at 37 °C, showing a fast peak and gradual return to basal levels. (B)
Cells pre-treatedwith 2 ng/ml IFNγ for 24 h, under perfusionwith 1mMATP, showing a fast peak that remained at high levels for several minutes. (C) Graph showing the time needed
for [Ca2+]i changes shown in A and B to return to basal levels. (D) same in B, with cells pre-treated for 2 h with oATP. The [Ca2+]i is given as the ﬂuorescence ratio (F340/F380 nm),
where ﬂuorescence is proportional to the intracellular calcium concentration. (E and F) Dose response curves for UTP-induced [Ca2+]i responses in untreated and IFNγ-treated cells,
respectively. (G) UTP was added in a bolus of 1-min duration, followed by a second 1-min bolus 5 min later, in calcium-free saline and a continuous perfusion chamber at room
temperature. Values in C represent mean±SEM of four (A) and ﬁve (B) independent experiments. n= 3 and n= 5 for curves shown in E and F, respectively. Values in G represent
mean±SEM of 3 independent experiments.
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Fig. 7. Proﬁle of ATP-activated currents in epithelial cells that were not treated with IFNγ. Whole cell currents were measured in HeLa cells kept at VH=−40 mV. (A) Transient
outward current after application of 1 mM ATP. (B and C) Transient outward currents after application of 100 μM UTP, showing a delay between stimulation with the nucleotide and
initiation of the outward current. None of the cells tested responded with inward currents (n= 11). (D and E) Outward current desensitization after successive stimulation with
100 μM UTP. The ﬁrst and second arrows indicate the fourth and ﬁfth application of UTP.
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observed in IFNγ-incubated cells (Fig 6D), further suggesting a
role for P2X7 in the ATP-dependent effects.
In order to investigate the possibility that IFNγ could be
affecting the activity of receptors other than P2X7, we also
characterized the effect of IFNγ on UTP-induced ﬂuxes. In
untreated cells, UTP promoted dose-dependent [Ca2+]i ﬂuxes
transiently, with an EC50 of 14 μM (Fig. 6E). The EC50 decreasedslightly (=9 μM) in IFNγ-incubated cells, but the UTP-induced
response clearly did not ﬁt a typical sigmoid curve (Fig. 6F),
suggesting the presence of more than one functional P2Y receptor
on IFNγ-incubated cells. Comparing the amplitude of the UTP-
induced calcium responses in untreated and IFNγ-treated cells, we
observed that two successive applications of 100 μM UTP induced a
rapid transient increase of [Ca2+]I in untreated cells, with similar
amplitudes both times (Fig. 6G), However, in IFNγ-incubated cells,
Fig. 8. IFNγ pre-treatment modiﬁes ATP-mediated currents. Whole cell currents were
measured in cells treated with 2 ng/ml IFNγ for 24 h and kept at a VH=−40 mV. (A) A
biphasic current induced immediately after ATP application. (B) Same cell as in A,
showing that while the outward component of the response disappeared, the inward
current does not desensitize. Note that the inward current starts immediately after ATP
stimulation. Two of six cells responded as shown in A and B, while four other cells
responded with outward currents, as shown for cells not treated with IFNγ.
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second response was smaller than the ﬁrst one (Fig. 6G).
3.7. ATP induces ion currents in HeLa cells
Application of 1 mM ATP induced an outward current in HeLa
cells after 10–15 s (Fig. 7A). The same transient outward currents
were observed in response to 100 μM UTP (Fig. 7B). Occasionally
the outward currents were biphasic or took place in multiples
steps, and displayed clear desensitization (Fig. 7C). We observed
almost complete outward current desensitization after four or ﬁve
successive applications of UTP (Fig. 7D). None of the cells tested
responded with an inward current. The behavior of the responses
was compatible with the activation of a Ca2+-activated K+ current,
similarly to the P2Y2-dependent response previously observed in
other cell types [45,46].
A very different response was observed in HeLa cells pre-treated
for 24 h with IFNγ. ATP application elicited biphasic responses
composed of a fast inward current followed by an outward current
(Fig. 8A). In some cells, we observed only the inward or the outward
component of the current (data not shown). After continued ATP
stimulation, the outward current disappeared, and only the inward
component remained (Fig. 8B).
4. Discussion
Purinergic signalling is an important component of host defence
against intracellular pathogens, mainly through activation of P2
receptors and particularly the P2X7 receptor [47]. The P2X7 receptor
is involved in elimination of mycobacteria and chlamydiae in infected
macrophages [9,11], and secretion of pro-inﬂammatory cytokines such
as IL-1β and IL-18 [48]. Extracellular ATP is released from infected orstressed cells, and is now viewed as a “danger signal” that, acting
through the P2X7 receptor, can stimulate secretion of pro-inﬂamma-
tory cytokines [49,50]. Ligation of the P2X7 receptor has also been
associated with homeostasis of T regulatory cells and regulation of
autoimmune disease [51–54].
Our experiments suggest that, in the absence of IFNγ stimula-
tion, HeLa cells express functional P2X7 at a low level. Although
P2X7 mRNA and P2X7 protein was detected in HeLa cells, the
functional experiments demonstrate that ATP treatment does not
elicit pore opening nor induce apoptosis, the two hallmarks of
functional P2X7 expression [1,55]. It has been proposed that a low
level of expression of this receptor makes it unresponsive to ATP
[56]. Similarly, it has recently been suggested that hetero-
oligomerization of P2X7 with a naturally occurring truncated
form of the receptor could block the receptor's function in HeLa
cells, as described by Feng et al. [35]. In support of this hypothesis,
we observed the presence of a 40 kDa band on gels from HeLa
cells that was not present in macrophage extracts, which could
correspond to the truncated form of P2X7. Another possibility is
that our antibody cross-reacts with a different splice variant, since
under our experimental conditions [56] we might not expect to
observe the 40 kDa band described by Feng et al. Regardless, the
new band disappears after IFNγ treatment, which is associated
with a change in the functional state of the P2X7 receptor.
Furthermore, IFNγ treatment clearly induces up-regulation of P2X7
receptor and activity, as revealed by an increase in the levels of P2X7
mRNA and protein, P2X7-dependent calcium ﬂuxes, and the presence
of non-desensitizing inward currents. Interestingly, we could not
detect the 40 kDa band in extracts of IFNγ-treated cells.
Most if not all cells express more than one subtype of P2
receptors [57]. But the observation that UTP-induced calcium
signaling in HeLa cells did not completely eliminate subsequent
ATP responses suggests that the cells express ATP receptors that
are not sensitive to UTP. We could not detect calcium signaling
using αβ-meATP at concentrations that activate P2X1–3 receptors,
implying that those P2X receptors are not functional in HeLa cells.
On the other hand, the outward currents observed after ATP and
UTP addition conﬁrm the functional presence of P2Y, possibly P2Y2
receptors, on the cells [58]. Our data on calcium ﬂuxes suggest the
presence of UDP-sensitive and ADP-sensitive P2Y receptors,
possibly P2Y6 and P2Y1 subtypes, but this conclusion will require
further studies. It has been proposed previously that P2Y2 receptors
on HeLa cells inhibit the activity of the Na+/K+-ATPase [33], but
unlike the present study, the authors were able to detect mRNA for
only the P2Y4 and P2Y6 subtypes on HeLa cells. Since P2Y4 in
humans is activated only by UTP [59], it should not be functional
in HeLa cells, despite being present at the transcriptional level, as
there were no UTP-induced calcium transients after perfusion with
ATP. Our measurement of calcium ﬂuxes in the presence of the
P2Y2 antagonist, suramin, conﬁrms the functional expression of
P2Y2 receptors on HeLa cells. The UTP dose–response curve and
sequential UTP pulses after IFNγ treatment suggest that this pro-
inﬂammatory cytokine upregulates additional P2Y receptors on
epithelial cells.
In conclusion, our study demonstrates that the most popular cell
type in cell biology laboratories expresses a functional P2X7 receptor,
which can be upregulated under the inﬂammatory conditions found
during microbial infection, thus amplifying inﬂammatory responses
requiring stimulation of a cytosolic “inﬂammasome“ by extracellular
danger signals [60,61]. Even though mRNA for a large number of
purinergic receptors is present, HeLa cells appear to express a smaller
subset of functional receptors, most likely for P2Y1, P2Y2 and P2Y6.
These receptors may also play a role in regulating essential functions
of the epithelial cells, such as maintenance of the Na+ and K+
gradients across the plasma membrane and controlling infection by
intracellular pathogens.
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